Osimertinib as Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: A Case Series

Background: Evidence of osimertinib as neoadjuvant therapy for resectable non-small cell lung cancer (NSCLC) are currently lacking. This case series study aimed to assess the safety and feasibility of neoadjuvant osimertinib therapy followed by surgery for resectable NSCLC.Materials and methods: Pat...

Full description

Saved in:
Bibliographic Details
Main Authors: Yan Hu (Author), Siying Ren (Author), Lulu Yang (Author), Zhongyi Tong (Author), Ruoyao Wang (Author), Wei Han (Author), Chao Zeng (Author), Jina Li (Author), Peng Xiao (Author), Li Wang (Author), Fenglei Yu (Author), Wenliang Liu (Author)
Format: Book
Published: Frontiers Media S.A., 2022-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available